Company intelligence
Cytosurge
FluidFM, the world's only technology to access, perturb, and profile the same living cell over time. #SameCell
About Cytosurge
Cytosurge drives the revolution in #SameCell Biology. With our proprietary FluidFM® technology, we provide the world's only platform to physically access, perturb, and profile the same living cell over time, empowering scientists to read, write, and analyze life as it unfolds. FluidFM OMNIUM: The platform for Same-Cell analysis. > Temporal Profiling: Perform non-destructive cytoplasmic biopsies for RNA-seq to track how baseline states causally drive future behavior. Move beyond snapshot correlations to true mechanistic understanding. > Mechanobiology: Leverage precise force control to measure adhesion, stiffness, and mechanical properties at the single-cell level. CellEDIT Service: Powered by FluidFM, vector-free, stoichiometrically controlled CRISPR engineering. We deliver precise, multiplex edits without viral toxicity—even in hard-to-transfect cells. You name it, we edit it. #SameCellBiology #FluidFM #TemporalProfiling #LiveSeq #scRNAseq #Mechanobiology #CRISPR #GeneEditing #Biotech #CellEDIT
Verified activity
Signals from Cytosurge
3 published signals
Presence & Recognition
Cytosurge participated in the ESCP 2026 event in Vienna, showcasing FluidFM OMNIUM in single-cell proteomics.
Reported by Cytosurge
Presence & Recognition
Cytosurge presented a poster on non-destructive, same-cell profiling with FluidFM OMNIUM at the ESCP 2026 event in Vienna.
Reported by Tobias Beyer
Research & Knowledge
Cytosurge featured FluidFM as a core biophysical tool across two different setups, including the ADD-ON and the OMNIUM platform.
Reported by Cytosurge